Peritoneal Mesothelioma

Peritoneal mesothelioma is a cancer of the peritoneum, the thin tissue lining the abdominal cavity and covering most abdominal organs. It is the second most common form of mesothelioma after the pleural type and is strongly linked to asbestos exposure. Symptoms often include abdominal swelling, pain, weight loss, and bowel changes, and diagnosis typically requires imaging followed by tissue biopsy.

Origin

The term combines "peritoneum" (from the Greek peritonaion, meaning "stretched around") with "mesothelioma," a name coined in the early 20th century for tumors arising from mesothelial cells. The causal link to asbestos was firmly established in the 1960s following Wagner's pleural studies, with peritoneal cases documented in heavily exposed workers shortly thereafter.

Significance in Asbestos Context

For patients, peritoneal mesothelioma matters because, unlike the pleural form, it is often more responsive to treatment, particularly cytoreductive surgery combined with heated intraperitoneal chemotherapy (HIPEC), and median survival can be substantially longer when treated at specialized centers. It is important to confirm the diagnosis with an experienced mesothelioma pathologist, since peritoneal tumors can be mistaken for ovarian cancer, gastrointestinal cancers, or benign conditions. From a legal standpoint, peritoneal mesothelioma is recognized as a signature asbestos-related disease; exposure histories may involve work with insulation, gaskets, brake linings, shipyard work, or secondary household exposure, and even modest exposures have been associated with the disease. Medical records documenting the histologic subtype (epithelioid, biphasic, or sarcomatoid), imaging findings, and any asbestos exposure history are central to both treatment planning and any claim.

Example Sentence

After months of unexplained abdominal bloating, a biopsy confirmed peritoneal mesothelioma, and her oncologist referred her to a center experienced in cytoreductive surgery with HIPEC.

Related Terms

Mesothelioma, Pleural Mesothelioma, HIPEC, Cytoreductive Surgery, Epithelioid Mesothelioma, Peritoneum

Notes

• Ask whether you are a candidate for cytoreductive surgery with HIPEC at a high-volume mesothelioma center. Outcomes are strongly tied to surgeon and center experience.
• Request that your biopsy slides be reviewed by a pathologist with mesothelioma expertise; misdiagnosis as ovarian or gastrointestinal cancer is common and changes both treatment and legal claims.
• Preserve a detailed occupational and household exposure history (jobs, products, locations, dates, family members' workplaces). Peritoneal mesothelioma can result from take-home exposure as well as direct work with asbestos.
• Confirm the histologic subtype (epithelioid, biphasic, sarcomatoid) in your pathology report, as it affects both prognosis and treatment options.
• Note that statutes of limitation for filing a claim typically run from the date of diagnosis, not from the date of exposure, so timing matters once a diagnosis is confirmed.